Background Concerns regarding potential neurological complications of COVID-19 are
being increasingly reported, primarily in small series. Larger studies have been limited by …

Objective To determine the relation of gray matter (GM) and white matter (WM) brain
volumes, and WM lesion load, with clinical outcomes 20 years after first presentation with …

Importance Longer-term outcomes and risk factors associated with myelin oligodendrocyte
glycoprotein antibody–associated disease (MOGAD) are not well established. Objective To …

Background and Objectives Acute inflammatory CNS diseases include neuromyelitis optica
spectrum disorders (NMOSDs) and myelin oligodendrocyte glycoprotein antibody …

Objective Myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) can
be monophasic or relapsing, with early relapse being a feature. However, the relevance of …

The negative impact of smoking in multiple sclerosis is well established; however, there is
much less evidence as to whether smoking cessation is beneficial to progression in multiple …

Brain atrophy, thought to reflect neuroaxonal degeneration, may be considered an objective
marker of disease progression in multiple sclerosis (MS). Our objective was to estimate …

Objectives Using current diagnostic criteria, patients who present with a clinically isolated
syndrome (CIS) may develop multiple sclerosis (MS) by subsequently exhibiting …

In a cohort of 275 Caucasians with a broad IGE phenotype, patients with absences were
classified. Criteria of the 1989 Commission on Classification of the International League …

Lifestyle and environmental factors are key determinants in disease causality and
progression in neurological conditions, including multiple sclerosis (MS). Lack of exercise …